Llwytho...
LKB1/AMPK Pathway and Drug Response in Cancer: A Therapeutic Perspective
Inactivating mutations of the tumor suppressor gene Liver Kinase B1 (LKB1) are frequently detected in non-small-cell lung cancer (NSCLC) and cervical carcinoma. Moreover, LKB1 expression is epigenetically regulated in several tumor types. LKB1 has an established function in the control of cell metab...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Oxid Med Cell Longev |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Hindawi
2019
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6874879/ https://ncbi.nlm.nih.gov/pubmed/31781355 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/8730816 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|